Literature DB >> 24033287

Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases.

C Fallerini1, L Dosa, R Tita, D Del Prete, S Feriozzi, G Gai, M Clementi, A La Manna, N Miglietti, R Mancini, G Mandrile, G M Ghiggeri, G Piaggio, F Brancati, L Diano, E Frate, A R Pinciaroli, M Giani, P Castorina, E Bresin, D Giachino, M De Marchi, F Mari, M Bruttini, A Renieri, F Ariani.   

Abstract

The mode of inheritance of Alport syndrome (ATS) has long been controversial. In 1927, the disease was hypothesized as a dominant condition in which males were more severely affected than females. In 1990, it was considered an X-linked (XL) semidominant condition, due to COL4A5 mutations. Later on, a rare autosomal recessive (AR) form due to COL4A3/COL4A4 mutations was identified. An autosomal dominant (AD) form was testified more recently by the description of some large pedigrees but the real existence of this form is still questioned by many and its exact prevalence is unknown. The introduction of next generation sequencing (NGS) allowed us to perform an unbiased simultaneous COL4A3-COL4A4-COL4A5 analysis in 87 Italian families (273 individuals) with clinical suspicion of ATS. In 48 of them (55%), a mutation in one of the three genes was identified: the inheritance was XL semidominant in 65%, recessive in 4% and most interestingly AD in 31% (15 families). The AD form must therefore be seriously taken into account in all pedigrees with affected individuals in each generation. Furthermore, a high frequency of mutations (>50%) was shown in patients with only 1 or 2 clinical criteria, suggesting NGS as first-level analysis in cases with a clinical suspicion of ATS.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Alport syndrome; COL4A3, COL4A4 and COL4A5 genes; autosomal dominant; molecular diagnosis; next generation sequencing

Mesh:

Substances:

Year:  2013        PMID: 24033287     DOI: 10.1111/cge.12258

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  53 in total

1.  Improving mutation screening in familial hematuric nephropathies through next generation sequencing.

Authors:  Vincent Morinière; Karin Dahan; Pascale Hilbert; Marieline Lison; Said Lebbah; Alexandra Topa; Christine Bole-Feysot; Solenn Pruvost; Patrick Nitschke; Emmanuelle Plaisier; Bertrand Knebelmann; Marie-Alice Macher; Laure-Hélène Noel; Marie-Claire Gubler; Corinne Antignac; Laurence Heidet
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

2.  Autosomal Recessive Alport Syndrome Unveiled by Pregnancy.

Authors:  Erika R Drury; Isaac E Stillman; Martin R Pollak; Bradley M Denker
Journal:  Nephron       Date:  2019-08-13       Impact factor: 2.847

3.  Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members.

Authors:  Judy Savige
Journal:  Pediatr Nephrol       Date:  2018-11-30       Impact factor: 3.714

4.  Natural history of genetically proven autosomal recessive Alport syndrome.

Authors:  Masafumi Oka; Kandai Nozu; Hiroshi Kaito; Xue Jun Fu; Koichi Nakanishi; Yuya Hashimura; Naoya Morisada; Kunimasa Yan; Masafumi Matsuo; Norishige Yoshikawa; Igor Vorechovsky; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2014-03-15       Impact factor: 3.714

Review 5.  Syndromic Hearing Loss: A Brief Review of Common Presentations and Genetics.

Authors:  John D Gettelfinger; John P Dahl
Journal:  J Pediatr Genet       Date:  2018-01-04

6.  Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.

Authors:  Stefanie Weber; Katja Strasser; Sabine Rath; Achim Kittke; Sonja Beicht; Martin Alberer; Bärbel Lange-Sperandio; Peter F Hoyer; Marcus R Benz; Sabine Ponsel; Lutz T Weber; Hanns-Georg Klein; Julia Hoefele
Journal:  Pediatr Nephrol       Date:  2016-01-25       Impact factor: 3.714

Review 7.  Rare genetic causes of complex kidney and urological diseases.

Authors:  Emily E Groopman; Gundula Povysil; David B Goldstein; Ali G Gharavi
Journal:  Nat Rev Nephrol       Date:  2020-08-17       Impact factor: 28.314

8.  Self-Assembled Peptide-Based Biocomposites for Near-Infrared Light Triggered Drug Release to Tumor Cells.

Authors:  Rachel E Daso; Ipsita A Banerjee
Journal:  Biotechnol J       Date:  2020-09-15       Impact factor: 4.677

9.  A Novel COL4A5 Splicing Mutation Causes Skipping of Exon 14 in a Chinese Family with Alport Syndrome.

Authors:  Erzhi Gao; Xi Yang; Nuo Si; Keqiang Liu; Jin-Quan Wang; Zhihong Liu
Journal:  Kidney Dis (Basel)       Date:  2019-10-22

Review 10.  Expert consensus guidelines for the genetic diagnosis of Alport syndrome.

Authors:  Judy Savige; Francesca Ariani; Francesca Mari; Mirella Bruttini; Alessandra Renieri; Oliver Gross; Constantinos Deltas; Frances Flinter; Jie Ding; Daniel P Gale; Mato Nagel; Michael Yau; Lev Shagam; Roser Torra; Elisabet Ars; Julia Hoefele; Guido Garosi; Helen Storey
Journal:  Pediatr Nephrol       Date:  2018-07-09       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.